Niels Borgstein
Corporate Officer/Principal bei ALKERMES PLC
Profil
Niels Borgstein is a professional with a doctorate degree from the University of Groningen.
He is currently working as SVP-Late Stage Clinical Development at Alkermes Plc.
Prior to this, he worked as Senior Director at Stryker Biotech LLC, Principal at Pfizer Inc., Vice President & Head-Clinical Development at Ironwood Pharmaceuticals, Inc., and Vice President-Medical Research at Acceleron Pharma, Inc.
Aktive Positionen von Niels Borgstein
| Unternehmen | Position | Beginn |
|---|---|---|
| ALKERMES PLC | Corporate Officer/Principal | 01.01.2021 |
Ehemalige bekannte Positionen von Niels Borgstein
| Unternehmen | Position | Ende |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Stryker Biotech LLC
 Stryker Biotech LLC Medical SpecialtiesHealth Technology Part of Stryker Corp., Stryker Biotech LLC develops, manufactures and markets surgical and medical products. The company is based in Hopkinton, MA. | Direktor/Vorstandsmitglied | - |
| PFIZER, INC. | Corporate Officer/Principal | - |
| ACCELERON PHARMA INC. | Corporate Officer/Principal | - |
Ausbildung von Niels Borgstein
| University of Groningen | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| ALKERMES PLC | Health Technology |
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis on June 13, 2003 and is headquartered in Rahway, NJ. | Health Technology |
Stryker Biotech LLC
Stryker Biotech LLC Medical SpecialtiesHealth Technology Part of Stryker Corp., Stryker Biotech LLC develops, manufactures and markets surgical and medical products. The company is based in Hopkinton, MA. | Health Technology |
